• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. No Sign of Slowdown in Biotech M&A

    High levels of merger and acquisition activity will be the big theme of year for biotech, says Morningstar's Lauren Migliore.

  2. Our Top Five Biotech Acquisition Candidates

    M&A activity grew in 2010, and we expect deal volume to remain strong in 2011.

  3. Top Biotech Acquisition Candidates

    2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.

  4. Our Top Five Biotech Takeout Picks

    Health-care analyst Lauren Migliore looks at what makes a biotech firm a likely takeout candidate and reveals our top five biotech M&A picks for 2010.

  1. Bristol-Myers Squibb Company BMY Q4 2010 Earnings Call Transcript

    Good day everyone, and welcome to today's Bristol-Myers Squibb Fourth Quarter Earnings 2010 Earnings Release Conference Call. Today's call is being recorded.

  2. Bristol-Myers Squibb Company BMY Q3 2010 Earnings Call Transcript

    Good day, and welcome to today's Third Quarter Earnings 2010 Earnings Release Conference Call. This call is being recorded.

  3. Bristol-Myers Squibb Company BMY Q3 2012 Earnings Call Transcript

    Good day, and welcome to today's Third Quarter 2012 Earnings Release Conference Call. As a reminder, this call is being recorded.

  4. Bristol-Myers Squibb Company BMY Q2 2011 Earnings Call Transcript

    Good day and welcome to today's Second Quarter 2011 Earnings Conference Call. This call is being recorded.

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.